Self reports of post-vaccination outcome by COVID-19 vaccine recipients across various study settings: An electronic survey

Debabrata Roy; Richa Sinha; Sonam Maheshwari; Priyanka Dobhal

doi:10.53730/ijhs.v6nS6.10978

Authors

Debabrata Roy Professor & Head, Department of Community Medicine, Government Doon Medical College, Dehradun
Richa Sinha Assistant Professor, Department of Community Medicine Government Doon Medical College, Dehradun
Sonam Maheshwari Assistant Professor cum Statistician, Department of Community Medicine, Government Doon Medical College, Dehradun
Priyanka Dobhal
priyankadobhal2302@gmail.com
Assistant Professor, Department of Community Medicine, Government Doon Medical College, Dehradun

Keywords:

COVID-19, post-vaccination, co-morbidity

Abstract

Background India rolled out its vaccination program against COVID 19 on and from 16th January 2021. Apart from preventive measures like Covid Appropriate Behavior, vaccines were introduced as key specific protection against the virus in several parts of world. The present study is designed to profile spectrum of post vaccination outcome in terms of clinical signs/symptoms including adverse effects encountered among recipients across India. Methods: An online cross-sectional survey was conducted among 188 vaccine recipients of more than 18 years of age through snow ball sampling using a semi- structured, pre tested instrument with appropriate questions after taking informed consent. Results: In this study 12.7 % were found to have tested positive for COVID-19 and 28.7 %were having various co-morbidity. Among all co-morbidities hypertension, diabetes and obesity were statistically significant with Covid status of the patients. ‘Pain at injection site’ was the most common symptom observed among Covid-19 positive and negative groups. A significant difference was observed between proportions of recipients with ‘fever’, ‘chills’ and ‘fatigue’ implying an association between test status for Covid and the symptoms. Within first 24 hours, 38.5% people had experienced ‘arthralgia’ and 71% of the people had reported ‘pain at injection site’.

Downloads

Download data is not yet available.

References

Cui, J., Li, F. & Shi, Z. L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17: 181–192.

Danabal KGM, Magesh SS, Saravanan S, Gopichandran V. Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India – a community based survey. BMC Health Services Research 2021; 21: 994.

Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proceedings of the National Academy of Sciences. 2020 Apr 28;117(17):9490-6.)

Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. The lancet 2021 May, Vol 21.

Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20.

Kakkar A, Gogia A, Sipani S, Gulati S, Batra T, Jain K, Jain S, Tripathi S. COVID vaccines: A step towards ending the pandemic. Current Medicine Research and Practice 2021 Jan-Feb;11:1 (26).

Khidoyatova, M. R., Kayumov, U. K., Inoyatova, F. K., Fozilov, K. G., Khamidullaeva, G. A., & Eshpulatov, A. S. (2022). Clinical status of patients with coronary artery disease post COVID-19. International Journal of Health & Medical Sciences, 5(1), 137-144. https://doi.org/10.21744/ijhms.v5n1.1858

Kumar BP, Paul P, Ghosh S, Ravindra BN, Roy AD. General awareness and safety measures to combat covid-19.)

Ministry of Health and Family Welfare, FAQ: COVID-19 Vaccination. Government of India, New Delhi; 2021. Available at: https://www.mohfw.gov.in/covid_vaccination/vaccination /index.html (accessed March 281 2021).

Sah R, Shrestha S Mehta R Sah SK Rabaan AA Dhama K. AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal. Travel Medicine and Infectious Disease 40 (2021) 101989.

Sica, A.; Casale, D.; Rossi, G.; Casale, B.; Ciccozzi, M.; Fasano, M.; Ciotti, M.; Sagnelli, E.; Papa, A.; Sagnelli, C. The impact of the SARS-CoV-2 infection, with special reference to the haematological setting. J. Med. Virol. 2020.

Srivastava RK, IshP , Safdarjung COVID-19 Vaccination group. The initial experience of COVID-19 vaccination from a tertiary care centre of India. Monaldi Arch Chest Dis 2021;91:1816.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864

Wang A, Zhao W, Xu Z, Gu J. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease COVID 19 is urgently needed Diabetes Res Clin Pract. 2020;162:108-118.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020 Mar 17;323(11):1061-9.

Wang, Y.; Wang, Y.; Chen, Y.; Qin, Q.J. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. Med. Virol. 2020, 92, 568–576.

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 COVID 19 outbreak in China: Summary of a report of 72,314 cases from the Chinese Centre for Disease Control and Prevention JAMA. 2020 doi: 101001/jama 2020-2648.